Pending

HPA Axis Study in Japanese Adults
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis
Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis
Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo
A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis
Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending-Dose Study of Hte Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of XmAb27564 in Patients With Plaque Psoriasis
A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults With Moderate to Severe Chronic Hand Eczema
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Treatment of Nighttime Pruritus in Atopic Dermatitis
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis
A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy
A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults
Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).
Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects
POC Study to Evaluate BSI-045B Monotherapy and BSI-045B add-on Therapy With Dupilumab in Atopic Dermatitis
A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
Topical Ruxolitinib Evaluation in Chronic Hand Eczema (Tru-CHE)
A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD)
Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis
Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis
A Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Exploratory Clinical Activity of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)
Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
Alitretinoin in the Treatment of Chronic Hand Eczema
A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis
A First-in-Human Study of QY211 Gel in Adult Subjects
Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
An Evaluation of 9MW1911 Injection in Healthy Subjects
A Study of Hemay005 in Adult With Atopic Dermatitis
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)
Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers
A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)
A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD)
Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis
The Study of CM326 in Adult Subjects With Atopic Dermatitis
The Study of CM326 in Moderate-to-severe Atopic Dermatitis
To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD
A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD
Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112
A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children
CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis
A Phase 3, Randomized, Double-Blind Study to Assess the Efficacy of Difamilast Ointment in Mild to Moderate AD
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus
A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients
Oral DS107 in Moderate to Severe Atopic Dermatitis
Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)
A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis
A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis
A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis
A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema
A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD
Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)
A Study of MG-K10 in Subjects With Atopic Dermatitis
Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%
Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis
Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis
Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis
Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)
A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials
Study of ATI-1777 in Patients 12 to 65 Years Old With Moderate or Severe Atopic Dermatitis
A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects
Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
A Study Evaluating AMG 451 in Moderate To-severe Atopic Dermatitis (ROCKET-IGNITE)

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis – TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis
A Safety, Tolerability and Preliminary Efficacy Study of BBI-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation
A Study To Learn About The Safety, Efficacy and Tolerability of PF-07038124 Ointment In Participants With Mild-To-Moderate Atopic Dermatitis Or Mild-To-Severe Plaque Psoriasis
A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India
A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color
IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema
Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis
A Study of Orally Administered IPG7236 in Healthy Adult Participants
A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)
Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study
A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis
A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)
A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis
5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 – 12 Months of Age With Mild to Moderate Atopic Dermatitis
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Eczema/Dermatitis and Dermal Pruritus (MK-4117-202)
Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects
A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Tralokinumab Administered With Device A in Adults and Adolescents With Moderate-to-severe Atopic Dermatitis
Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
Targeted Investigation of Microbiome Elimination
A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection
A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier
Phase 2b Study of Efficacy and Safety of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis
A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis
A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine
Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis
Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis
A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
Study Testing Response Effect of KY1005 Against Moderate to Severe Atopic Dermatitis The STREAM-AD Study
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis
Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis
Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis
A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects
Effect of Benralizumab in Atopic Dermatitis
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
Open-label Maximum Use Trial of Ruxolitinib Cream in Children With Atopic Dermatitis
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)
Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China
Comparison of JW-100 and EUCRISA®
A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial
A new era of atopic eczema research: Advances and highlights
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab
The Efficacy of Janus Kinase Inhibitors in Patients with Atopic Dermatitis: A Systematic Review and Network Meta-analysis
The treatment and management of atopic dermatitis in the pediatric emergency department: Highlighting physician practices and the desire for patient-centered resources
Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)
Allergic Disease Onset Prevention Study
The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczema
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis
Complete blood count profiles in children with eczema herpeticum
Current Clinical Options for the Management of Itch in Atopic Dermatitis
Narrow-band UVB combined with compound clobetasol propionate can improve the therapeutic effect in hand eczema patients
Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial
Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult
Using emollients to promote safe and effective skin care for patients
A comprehensive review of therapeutic approaches available for the treatment of dermatitis
Cannabinoids for skin diseases and hair regrowth
Skin Mast Cell-Driven Ceramides Drive Early Apoptosis in Pre-Symptomatic Eczema in Mice
Blue Light in Dermatology
The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study
Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis
Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial
A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
Reply to “Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A two-year case series of patient-reported outcomes”
Reply to “Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A 2-year case series of patient-reported outcomes”
Increased prevalence of irritant hand eczema in health care workers in a dermatological clinic due to increased hygiene measures during the SARS-CoV-2 pandemic
2020 Korean Consensus Guidelines for Diagnosis and Treatment of Chronic Hand Eczema
Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series
Frequent Eczematous Dermatitis in Unrelated Cord Blood Hematopoietic Cell Transplant Recipients Compared to Other Donor Types
Successful treatment of tinea capitis caused by Microsporum canis in a 23-day-old newborn with itraconazole pulse therapy and a review of the literature
Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis
Staphylococcal TSST-1 Association with Eczema Herpeticum in Humans
Association between Atopic Dermatitis and Hypertension: A Systematic Review and Meta-Analysis
Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
A Clinical Investigation of the Performance and Safety of Epaderm® , an Emollient Cream
Antibacterial and Anti-Inflammatory Potential of Polyherbal Formulation Used in Chronic Wound Healing
Cell-penetrating heme oxygenase-1 in the therapy of atopic dermatitis in mice

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis
Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
Difamilast ointment, a selective phosphodiesterase 4 inhibitor, in paediatric patients with atopic dermatitis: A phase 3 randomised double-blind, vehicle-controlled trial
Effect of dupilumab on sleep disturbances in adult patients with severe atopic dermatitis
A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis
Management of pediatric atopic dermatitis by primary care providers: A systematic review
Just another eczema case for you, but to me it’s the world
Atopic dermatitis: Conventional and Integrative Medicine
Treatment outcomes of patients with Atopic Dermatitis (AD) treated with dupilumab through the Early Access to Medicines Scheme (EAMS) in the UK
Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis
Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome
Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis
Interventions to improve primary care provider management of atopic dermatitis: A systematic review
Prospective, comparative clinical pilot study of cold atmospheric plasma device in the treatment of atopic dermatitis
Potential Acupoint Prescriptions and Outcome Reporting for Acupuncture in Atopic Eczema: A Scoping Review
The Anti-Inflammatory Effect of a γ-Lactone Isolated from Ostrich Oil of Struthio camelus (Ratite) and Its Formulated Nano-Emulsion in Formalin-Induced Paw Edema
Identification and characterization of quinoline alkaloids from the root bark of Dictamnus dasycarpus and their metabolites in rat plasma, urine and feces by UPLC/Qtrap-MS and UPLC/Q-TOF-MS
Vesicular hand eczema transcriptome analysis provides insights into its pathophysiology
Improvement of skin lesions in corticosteroid withdrawal-associated severe eczema by multicomponent traditional Chinese medicine therapy
Epidemiology of skin event rates among users of pumps for the subcutaneous administration of drugs for chronic conditions
Atopic Eczema: Pathophysiological Findings as the Beginning of a New Era of Therapeutic Options
Safety of topical corticosteroids in atopic eczema: an umbrella review
Advances in the Translational Science of Dermatitis
Measurement properties of patient-reported outcome measures (PROMs) in patients with hyperhidrosis: protocol for a systematic review
Investigation of the prevalence of hand eczema among healthcare professionals in Turkey: a cross-sectional study
Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis
Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials
What is the most effective systemic treatment for Atopic Dermatitis?
Systemic Antiviral Dosing in Eczema Herpeticum
A prospective randomized controlled study of the therapeutic effects of a self-developed novel low-temperature boric acid wet dressing on the face and neck wounds of patients with superficial burns
Hand Hygiene Habits and Prevalence of Hand Eczema During the COVID-19 Pandemic
Young adults’ perceptions of living with atopic dermatitis in relation to the concept of self-management: a qualitative study
An analysis of qualitative responses from a UK survey of the psychosocial wellbeing of people with skin conditions and their experiences of accessing psychological support
Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study
Effects of Deacetylasperulosidic Acid on Atopic Dermatitis through Modulating Immune Balance and Skin Barrier Function in HaCaT, HMC-1, and EOL-1 Cells
Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents
Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice
New topical treatments for atopic dermatitis – active comparators are needed
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry
Bronchopleural fistula in a 5- years old child with novel CARMIL 2 mutation: A rare disease and a rare case
Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: A case series
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials
Prevalence of Allergic Rhinitis and Eczema in Adolescents Living in Yazd City: Part of Global Asthma Network Survey
Gut microbiome skin axis in the development of atopic dermatitis
Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis: A Randomized Double-blind Clinical Trial
Efficacy and Safety of FMX114 Versus Vehicle in Adults With Atopic Dermatitis
EDP1867 Phase 1a/1b Study in Healthy Participants and Participants With Moderate Atopic Dermatitis and, Optionally, Moderate Psoriasis, and/or Mild Asthma
Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study
Assessment of hand or foot eczema and contact dermatitis among car mechanics
An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
Handeczema and occupational health and safety measures
Current Perspectives on the Systemic Management of Atopic Dermatitis
Challenge of food allergy testing and avoidance in children with atopic dermatitis
Cutaneous manifestations related to the COVID-19 pandemic: a review article
Lineage-Specific Chimerism and Outcome After Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency
What’s new in atopic eczema? An analysis of systematic reviews published in 2019. Part 2: Treatment
Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab
Postoperative contact dermatitis caused by skin adhesives used in orthopedic surgery: Incidence, characteristics, and difference from surgical site infection
Diagnosis and Management of Dermatitis, Including Atopic, Contact, and Hand Eczemas
Can Mixed Strains of Lactobacillus and Bifidobacterium Reduce Eczema in Infants under Three Years of Age? A Meta-Analysis
Systems Pharmacology and In Silico Docking Analysis Uncover Association of CA2, PPARG, RXRA, and VDR with the Mechanisms Underlying the Shi Zhen Tea Formula Effect on Eczema
The Role of the Environment and Exposome in Atopic Dermatitis
Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double blinded placebo controlled interventional study
A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.
Clinical Observation of the Correlation Between Overactive Bladder and Atopic Constitution in Children
Itch in Atopic Dermatitis – What Is New?
Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
Experimental Drugs with the Potential to Treat Atopic Eczema
Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)
Internet-Delivered Cognitive Behavior Therapy for Atopic Dermatitis: A Randomized Clinical Trial
Educational intervention and atopic dermatitis: impact on quality of life and treatment
Open-label Study of CM310 in Patients With Atopic Dermatitis
Advances in atopic dermatitis
Evaluation of Spin in the Abstracts of Systematic Reviews and Meta-Analyses of Atopic Dermatitis Treatments and Interventions
Evidence-based management of eczema: five things that should be done more and five things that should be dropped
Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis
Long-term efficacy and safety of intravenous injection of clonal mesenchymal stem cells derived from bone marrow in five adults with moderate to severe atopic dermatitis
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials
Treatment with alitretinoin in patients taking part in a tertiary individual prevention programme for work-related skin diseases
Illness perceptions of adults with eczematous skin diseases: a systematic mixed studies review
A Clinical Case Report of a Potential Acute Allergic Reaction with Titanium Dental Implant
Efficacy and Safety of Qingpeng Ointment for Subacute and Chronic Eczema: A Systematic Review and Meta-Analysis
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Fungal asthma among Ugandan adult asthmatics
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
The effect of γ-linolenic acid on Polycystic Ovary Syndrome associated Focal Segmental Glomerulosclerosis via TGF-β pathway
Increased Prevalence of Alcohol Use Disorder (AUD) in Psoriasis and Dermatitis (Eczema)
Application of Janus Kinase Inhibitors in Atopic Dermatitis: An Updated Systematic Review and Meta-Analysis of Clinical Trials
The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
Impact of an e-learning program on pharmacists’ management of atopic dermatitis
Effect of Weight Reduction on Treatment Outcomes for Patients with Atopic Dermatitis
Keratinocytes-Derived Reactive Oxygen Species Play an Active Role to Induce Type 2 Inflammation of the Skin: A Pathogenic Role of Reactive Oxygen Species at the Early Phase of Atopic Dermatitis
Alitretinoin Compliance in Patients with Chronic Hand Eczema
Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis

A feasibility study of the burden of disease of atopic dermatitis using a smartphone research application, myEczema
Treatment of patients with atopic dermatitis with weekly dupilumab dosing: a single institutional retrospective medical record review and survey
Protein-losing enteropathy in an infant with severe atopic dermatitis
Shifts in the Skin Microbiota after UVB Treatment in Adult Atopic Dermatitis
Dupilumab treatment induced similar improvements in signs, symptoms, and quality of life in adults with moderate-to-severe atopic dermatitis with baseline Eczema Area and Severity Index score < 24 or 24
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn’s disease
Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma: A Systematic Review and Meta-analysis
Real-world comorbidities of atopic dermatitis in the pediatric ambulatory population in the United States
Prevalence and psychosocial impact of atopic dermatitis in Bangladeshi children and families
Nomenclature and clinical phenotypes of atopic dermatitis
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
Effectiveness of ustekinumab in patients with atopic dermatitis: analysis of real-world evidence
Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis
Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study
Eczema herpeticum in atopic dermatitis
Epidemiology and Characterization of Atopic Dermatitis in East Asian Populations: A Systematic Review
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis
The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis
A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
Temporal Variation in Staphylococcus aureus Protein A Genotypes from Nose and Skin in Atopic Dermatitis Patients
Clinical phenotyping of atopic dermatitis using combined itch and lesional severity: A prospective observational study
Efficacy and Safety of Runzao Zhiyang Capsule as an Add-On Therapy for Chronic Eczema: A Systematic Review and Meta-Analysis
Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
Itchy Capillary Malformations: Unusual Appearance of Meyerson Phenomenon, a Case Series
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib
Differences in phototherapy among skin diseases and genders in real-life conditions – a retrospective analysis of the cumulative doses, numbers of sessions, side effects and costs in 561 patients
Radiation-irritated skin and hyperpigmentation may impact the quality of life of breast cancer patients after whole breast radiotherapy
Erratum: Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges [Corrigendum]
The emerging role of dupilumab in dermatological indications
Clinical Pattern and Patch Test Profile of Hand Eczema in Hospital Employees in a Tertiary Care Hospital of North India
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis
Dupilumab for Children and Adolescents with Atopic Dermatitis: An Asian Perspective
Tralokinumab Does Not Impact Vaccine-induced Immune Responses: Results From a 30-week, Randomized, Placebo-controlled Trial in Adults With Moderate-to-severe Atopic Dermatitis
Anti-inflammatory effect of leaves of Vernonia zeylanica in lipopolysaccharide-stimulated RAW 264.7 macrophages and carrageenan-induced rat paw-edema model
Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis
A description of treatment patterns of psoriasis by medical providers and disease severity in US women
Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)
Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
Cutaneous manifestations of patients with Human Immunodeficiency Virus (HIV) Infection: A retrospective review of a tertiary referral centre with clinicopathological correlation
Allergic contact dermatitis by ophthalmological medications in Brazil: experience of a dermatology department
Topical 0.05% clobetasol cream in the treatment of chronic hand eczema: A protocol for systematic review and meta-analysis
Melbourne Infant Study – Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis
Characterizing Skin Microbiome Change in Atopic Dermatitis
An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis
Treatment of Chronic Venous Ulcers With Heterologous Fibrin Sealant: A Phase I/II Clinical Trial
A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis
A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis
Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect
Rhinitis prevalence and association with atopic dermatitis: A systematic review and meta-analysis
Eczema Herpeticum in children with burns
Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
Reply to “Comment on ‘Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'”
Children’s Views and Experiences of Treatment Adherence and Parent/Child Co-Management in Eczema: A Qualitative Study
Spontaneous resolution of atopic dermatitis incidental to participation in benralizumab clinical trial for severe, uncontrolled asthma: a case report
Comment on “Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry”
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies
Real-world prevalence and burden of genital eczema in atopic dermatitis: A multicenter questionnaire-based study
Fifteen-minute consultation: How to manage eczema in children
Dupilumab treatment in atopic dermatitis patients in the Netherlands versus Japan: a comparative cohort study revealing a discrepancy in patient-reported outcome measures
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)
New evidence on the minimal important change (MIC) for the Hand Eczema Severity Index (HECSI)
Cohort study for long-term follow-up of patients in whom the so-called “molecular classifier” was used to distinguish eczema from psoriasis : Background and implementation
Analysis of animal model of atopic dermatitis based on characteristics of clinical symptoms traditional Chinese and Western medicine
Instrumental evaluation of skin barrier function and clinical outcomes during dupilumab treatment for atopic dermatitis: An observational study
Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)
The “dermatologist’s procedure” after the abolition of the obligation to refrain from risky work activities in occupational disease law
Appearance of Acute Inflammatory State Indicates Improvement in Atopic Dermatitis Cases Under Classical Homeopathic Treatment: A Case Series
Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous
Allergic Contact Dermatitis to VenaSeal After Chronic Venous Insufficiency Treatment Mimics Phlebitis
Beneficial effects of an alkaline topical treatment in patients with mild atopic dermatitis
Abrocitinib for atopic dermatitis – Authors’ reply
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study
The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial
Visual impairment in immunoglobulin G4-related disease: A case report
Switching from atopic dermatitis to psoriasis – and back
Colonization With Staphylococcus aureus in Atopic Dermatitis Patients: Attempts to Reveal the Unknown
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer
‘Not just a piece of skin in front of you’-a qualitative exploration of the experiences of adolescents with eczema and psoriasis with healthcare professionals
Biomarkers in atopic dermatitis – a review on behalf of the international eczema council
Mask-induced Koebner phenomenon and its clinical phenotypes: A multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics
Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis
Evaluation of bronchial challenge test results for use in assessment of paediatric eczema: a retrospective series
Skin care interventions in infants for preventing eczema and food allergy
Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone
Treatment Patterns in Danish Patients with Atopic Dermatitis Before and After Hospital Referral
Supporting self-care for eczema: protocol for two randomised controlled trials of ECO (Eczema Care Online) interventions for young people and parents/carers
Priority research questions in atopic dermatitis: An International Eczema Council eDelphi consensus
A Comparison of the Effect of Topical Preparation of Sambucus ebulus L. and Hydrocortisone on Hand Eczema: A Double-Blind Randomized Controlled Trial
Phototherapy
The “Maskne” microbiome – pathophysiology and therapeutics
The potential pathways underlying the association of propyl-paraben exposure with aeroallergen sensitization and EASI score using metabolomics analysis
Palmoplantar dermatoses in children
The Role of Photoprotection in Optimizing the Treatment of Atopic Dermatitis

Eczematous Drug Eruptions
An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial
Filaggrin gene mutations with special reference to atopic dermatitis
Atopic Dermatitis: A Patient and Dermatologist’s Perspective
Glucocorticoid Receptor Beta and Its Prognostic Value on Treatment Response in Chronic Vulvar Dermatitis
Treatment of eosinophilic pustular folliculitis with benralizumab in a 13-year-old girl
Public Interest in Dermatologic Symptoms, Conditions, Treatments, and Procedures during the COVID-19 Pandemic: Insights from Google Trends
Novel agents for atopic dermatitis in patients over 50 years of age: a case series
Traditional knowledge and practice of the Triassic variegated clay from Silesia (Krasiejów), Poland, in human medicine
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy Phase 3 trial in the United States and Canada (BREEZE-AD5)
Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review
Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): a real-life retrospective cohort multicentre study on 438 subjects with chronic hand eczema
In “High-Risk” Infants with Sufficient Vitamin D Status at Birth, Infant Vitamin D Supplementation Had No Effect on Allergy Outcomes: A Randomized Controlled Trial.
Use of calcium channel blockers in dermatology: a narrative review.
Efficacy and Safety Study of CD2027 Ointment 3 mcg/g Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis
Abrocitinib for atopic dermatitis – Authors’ reply.
Treatment of eosinophilic pustular folliculitis with benralizumab in a 13-year-old girl.
Novel agents for atopic dermatitis in patients over 50 years of age: a case series.
Atopic Dermatitis: A Patient and Dermatologist’s Perspective.
Glucocorticoid Receptor Beta and Its Prognostic Value on Treatment Response in Chronic Vulvar Dermatitis.
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Resveratrol Inhibits Particulate Matter-Induced Inflammatory Responses in Human Keratinocytes.
The “Maskne” microbiome – pathophysiology and therapeutics.
Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis
Systemic treatment in atopic dermatitis after 2018: from experienced-based treatment to evidence-based treatment?
Nipple eczema in an adolescent girl presenting with persistent unilateral nipple discharge.
A Comparison of the Effect of Topical Preparation of Sambucus ebulus L. and Hydrocortisone on Hand Eczema: A Double-Blind Randomized Controlled Trial.
Frequency and Clinical Features Associated With Eczema Herpeticum in Hospitalized Children With Presumed Atopic Dermatitis Skin Infection.
Supporting self-care for eczema: protocol for two randomised controlled trials of ECO (Eczema Care Online) interventions for young people and parents/carers.
Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.
Treatment Patterns in Danish Patients with Atopic Dermatitis Before and After Hospital Referral.
Evaluation of bronchial challenge test results for use in assessment of paediatric eczema: a retrospective series.
Skin care interventions in infants for preventing eczema and food allergy.
Crisaborole 2% Ointment for Mild-to-Moderate Atopic Dermatitis.
A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate AD
[Switching from atopic dermatitis to psoriasis – and back].
A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)
Biomarkers in atopic dermatitis – a review on behalf of the international eczema council.
‘Not just a piece of skin in front of you’-a qualitative exploration of the experiences of adolescents with eczema and psoriasis with healthcare professionals.
Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.
Colonization With Staphylococcus aureus in Atopic Dermatitis Patients: Attempts to Reveal the Unknown.
Case Report: Baricitinib Combined with Adjuvant Therapy for Treatment of Atopic Dermatitis in a Child.
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer.
Visual impairment in immunoglobulin G4-related disease: A case report.
Self-Reported Hand Eczema: Assessment of Prevalence and Risk Factors in Health Care Versus Non-Health Care Workers During the COVID-19 Pandemic.
Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis
Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression.
l-Histidine Supplementation in Adults and Young Children with Atopic Dermatitis (Eczema).
Health, educational and employment outcomes among children treated for a skin disorder: Scotland-wide retrospective record linkage cohort study of 766,244 children.
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
Therapeutic approach to skin reactions caused by personal protective equipment (PPE) during COVID-19 pandemic: An experience from a tertiary hospital in Granada, Spain.
The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial.
Washing with water alone versus soap in maintaining remission of eczema.
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
Beneficial effects of an alkaline topical treatment in patients with mild atopic dermatitis.
Allergic Contact Dermatitis to VenaSeal After Chronic Venous Insufficiency Treatment Mimics Phlebitis.
[Hand eczema in COVID-19 outbreak: whether or not to wear gloves?]
Effect of Extensively Hydrolyzed Casein vs. Conventional Formula on the Risk of Asthma and Allergies: the TRIGR Randomized Clinical Trial.
ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis
Postnatal probiotics and allergic disease in very preterm infants: Sub-study to the ProPrems randomized trial.
Childhood granulomatous periorificial dermatitis: case report and review of the literature.
Moisturizing effect of skin patches with hydrophobic and hydrophilic electrospun fibers for atopic dermatitis.
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges.
Glucocorticoid-Induced Skin Atrophy: The Old and the New.
Mesotherapy with Snake Venom Pharmacopuncture to Treat Hand Eczema: Two Cases Report.
Taking charge of eczema self-management: a qualitative interview study with young people with eczema.
A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis
Hand dermatitis in nurses: is promotion of protective behaviour ineffective?
Are skin equipment for assessing childhood eczema any good?
Sensitisation to aeroallergens in relation to asthma and other allergic diseases in Angolan children: a cross-sectional study.
A Community-based Assessment of Skin Care, Allergies, and Eczema (CASCADE): an atopic dermatitis primary prevention study using emollients-protocol for a randomized controlled trial.
Live-interactive teledermatology program in Taiwan: One-year experience serving a district hospital in rural Taitung County.
A Systematic Review of Eczematous Eruptions in Patients Receiving Biologic Therapy.
A case report of uveitis secondary to dupilumab treatment for atopic dermatitis.
Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in children.
Probiotics in the Management of Atopic Dermatitis for Children: A Case-Based Review.
To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis
Inhibition of IL-13: A New Pathway for Atopic Dermatitis.
The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study.
Dupilumab in Japanese Patients With Atopic Dermatitis
An Observational Study of the Application of a Topical Cannabinoid Gel on Sensitive Dry Skin.
A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
Effects of variations in access to care for children with atopic dermatitis.
Dupilumab therapy of atopic dermatitis of the elderly: a multi-centre, real-life study.
Dupilumab in Elderly Patients With Severe Atopic Dermatitis.
8-Week Atopic Dermatitis (AD) Treatment Study
Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis
Rhinacanthus nasutus “Tea” Infusions and the Medicinal Benefits of the Constituent Phytochemicals.
Does it work and is it safe? Parents’ perspectives on adherence to medication for atopic dermatitis.
Food restriction, nutrition status, and growth in toddlers with atopic dermatitis.
Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.
Tissue-resident memory T cells in the skin.
Atopic dermatitis and psychosocial comorbidities.
Traditional Chinese Medicine for Food Allergy and Eczema.
Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A two-year case series of patient-reported outcomes.

Paediatric atopic eczema (atopic dermatitis) in South Africa: A practical algorithm for the management of mild-to-moderate disease in daily clinical practice.
Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre.
A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil
Psoriatic arthritis with skin lesions localized to the scalp: A case report.
Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-07038124 Ointment In Participants With Atopic Dermatitis or Plaque Psoriasis
The role of the nurse in the care and management of patients with atopic dermatitis.
Prevalence of skin diseases in children 1 to 6 years old in the city of Bogota, Colombia.
A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
Dietary prebiotics promote intestinal Prevotella in association with a low-responding phenotype in a murine oxazolone-induced model of atopic dermatitis.
Effects of a self-efficacy theory-based parental education program on eczema control and parental outcomes.
A Case of Lichen Planus Masquerading as Guttate Psoriasis.
Eczema-like Eruption Limited to the Right Sole: Localised Scabies.
Eczema in elderly people.
The effect of water hardness on atopic eczema and skin barrier function: A systematic review and meta-analysis.
Les scores d’évaluation de la dermatite atopique: Outcome measures for atopic dermatitis.
Bidirectional Association between Atopic Dermatitis, Conjunctivitis and other Ocular Surface Diseases: A Systemic Review and Meta-Analysis.
Mode of action of urea.
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale.
Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib.
Assessment of Impairment of Quality of Life in Foot Eczema and Correlation thereof with Epidemiological Data of its Patients: A Cross-Sectional Study.
Probiotics in the prevention and treatment of atopic dermatitis.
A Study to Test the Safety, Pharmacokinetics and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis
Nano- and Microfiber PVB Patches as Natural Oil Carriers for Atopic Skin Treatment.
Allergic contact dermatitis of the hands caused by thiurams in bicycle cuffs.
Case of autoimmune progesterone dermatitis presenting as necrotic migratory erythema successfully controlled by danazol.
An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature.
Parents and GPs’ understandings and beliefs about food allergy testing in children with eczema: qualitative interview study within the Trial of Eczema allergy Screening Tests (TEST) feasibility trial.
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis – ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)
Treatment of superficial Basal Cell Carcinoma with 7.8% 5-aminolaevulinic acid % nanoemulsion-based gel (BF-200 ALA) and Photodynamic Therapy: results in clinical practice in a Tertiary Hospital.
Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis.
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.
Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitis
The potential role of cannabinoids in dermatology.
Dupilumab treatment of nummular dermatitis: A retrospective cohort study.
High incidence of hand eczema in Danish schoolchildren following intensive hand hygiene during the COVID-19 pandemic: a nationwide questionnaire study.
Oral administration of Jumihaidokuto inhibits UVB-induced skin damage and prostaglandin E2 production in HR-1 hairless mice.
Beneficial Effects of Paraffin Bath Therapy as Additional Treatment of Chronic Hand Eczema: A Randomized, Single-Blind, Active-Controlled, Parallel-Group Study.
[Persistent, unilateral eczema of the nipple in a man].
Does daily bathing or showering worsen atopic dermatitis severity? A systematic review and meta-analysis.
Tracing the Photoaddition of Pharmaceutical Psoralens to DNA.
Feeding-based treatment of allergic proctocolitis and associated clinical outcomes.
Current Perspectives on the Management of Infantile Atopic Dermatitis.
[Successful treatment of chronic prurigo with dupilumab].
DISCERN Scores of YouTube Information on Eczema Treatments.
[Fatal outcome of Netherton syndrome due to excessive use of topical corticosteroids in an adult patient].
JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results.
Patterns and trends in eczema management in UK primary care (2009-2018): a population-based cohort study.
A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)
Predictors of hospital readmission in United States adults with psoriasis.
Factors and cost associated with atopic dermatitis in Nevada.
Cardiospermum halicacabum in atopic dermatitis: clinical evidence based on phytotherapic approach.
Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: Clinical aspects and treatment outcomes in adolescent and adult patients.
Exposure-Response Analyses for Upadacitinib Efficacy in Subjects with Atopic Dermatitis – Analyses of Phase 2b Study to Support Selection of Phase 3 Doses.
BIOLOGICAL TREATMENTS IN ALLERGY: PRESCRIBING PATTERNS AND MANAGEMENT OF HYPERSENSITIVITY REACTIONS.
Feasibility Study for the Long-Term Management of Refractory Hyperkeratotic Eczema with Calcipotriol and Betamethasone Dipropionate (Daivobet®), Viaminate and Concomitant Conventional Therapies: A Retrospective Study.
Prevalence of atopic dermatitis, asthma and rhinitis from infancy through adulthood in rural Bangladesh: a population-based, cross-sectional survey.
Therapeutic Considerations Related to Stress Levels Associated with Hand Eczema: A Clinico-Etiological Study.
Anti-inflammatory mechanism and active ingredients of the Chinese tallow tree.
The impact of vitamin D supplementation as an adjuvant therapy on clinical outcomes in patients with severe atopic dermatitis: A randomized controlled trial.
Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.
Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis
Dermatological side effects of immunotherapy drugs and targeted cancer therapies: Importance of dermatology and oncology collaboration.
A First-in-Human Study of CEE321 in Adult Subjects
Creating a Smartphone App for Caregivers of Children With Atopic Dermatitis With Caregivers, Health Care Professionals, and Digital Health Experts: Participatory Co-Design.
Successful treatment of erythematous-squamous disorders of the external auditory canal with tacrolimus and clotrimazole in otic oil: our experience in 25 patients.
The risk of hand eczema in healthcare workers during the COVID-19 pandemic: Do we need specific attention or prevention strategies?
[To the question of the possibility of using selective chromotherapy for allergic diseases in children].
Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one-year observational cohort study of the first 100 patients treated.
Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis
Management of Atopic Dermatitis in Children Younger Than Two Years of Age by Community Pediatricians: A Survey and Chart Review.
Hydroxyurea-induced superinfected ulcerations: Two case reports and review of the literature.
Content analysis of psoriasis and eczema direct-to-consumer advertisements.
StatPearls
Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.
[Isolated unilateral eczema of the eyelid in a child].
Medical algorithm: Diagnosis of Atopic Dermatitis in Early Childhood (part I).
Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis
Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
Efficacy of Pumpkin Ointment in Treatment of Chronic Hand Eczema: A Randomized, Active-Controlled, Double Blind Clinical Trial.
Allergic contact dermatitis in patients with atopic dermatitis: A retrospective study.
Biotinidase deficiency characterized by skin and hair findings.
Current and Emerging Biologics for the Treatment of Pediatric Atopic Dermatitis.
Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition.
Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients.
When WAS Gene Diagnosis Is Needed: Seeking Clues Through Comparison Between Patients With Wiskott-Aldrich Syndrome and Idiopathic Thrombocytopenic Purpura.
Hand eczema pandemic caused by severe acute respiratory syndrome coronavirus 2 hygiene measures: the set-up of a hand eczema helpline for hospital personnel.
Medical algorithm: Treatment of atopic dermatitis in early childhood (part II).
Advances and novel developments in mechanisms of allergic inflammation.
Vitamin E in Atopic Dermatitis: From Preclinical to Clinical Studies.
A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis
Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis
Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia.
[Wound treatment in diabetes patients and diabetic foot ulcers].
Transcutaneous Slowly Depolarizing Currents Elicit Pruritus in Patients with Atopic Dermatitis.
ARTICLE: Colloidal Oatmeal Part II: Atopic Dermatitis in Special Populations and Clinical Efficacy and Tolerance Beyond Eczema.
Reporting Quality of Randomized Controlled Trials for the Treatment of Eczema with Chinese Patent Medicine Based on the CONSORT-CHM Formulas 2017.
Oxidative stress as a treatment target in atopic dermatitis: The role of furfuryl palmitate in mild-to-moderate atopic dermatitis.
Staphylococcus aureus Second Immunoglobulin-Binding Protein drives atopic dermatitis via IL-33.
Treatment of paediatric eczema with narrow band ultraviolet light B therapy.

Allergic rhinoconjunctivitis.
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.
Hepatitis C virus associated Skin Manifestations in Upper Egypt: Before and after Direct Acting Antiviral Treatment.
Clearance of molluscum contagiosum virus infection in patients with atopic eczema treated with dupilumab.
Topical Doxycycline Monohydrate Hydrogel (NANODOX®) 1% targeting proteases/PAR2 pathway is a novel therapeutic for Atopic Dermatitis.
Dupilumab treatment ameliorates clinical and hematological symptoms, including blood eosinophilia, in patients with atopic dermatitis.
A behaviour change package to prevent hand dermatitis in nurses working in health care: the SCIN cluster RCT.
Beneficial Effects of Adding Topical Atorvastatin 5% Cream to Topical Betamethasone 1% Ointment on Chronic Hand Eczema.
Pediatric Diabetes and Skin disease (PeDiSkin): a cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes.
Long-term impact of giving antibiotics before skin incision versus after cord clamping on children born by caesarean section: protocol for a longitudinal study based on UK electronic health records.
Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT.
[Randomized controlled trial on application of negative pressure materials of polyvinyl alcohol and polyurethane in full-thickness burn wounds after escharotomy].
Self-administered daylight-activated photodynamic therapy for the treatment of hand eczema: a prospective proof-of-concept study.
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled, severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study.
Abrocitinib for the treatment of atopic dermatitis.
A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis
Self-perceived disease control in childhood eczema.
Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.
Symptom burden of atopic dermatitis in early childhood assessed from daily monitoring of symptoms and topical steroid usage.
Secukinumab-induced pompholyx in a psoriasis patient.
Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases.
Solanum nigrum Linne improves DNCB‑induced atopic dermatitis‑like skin disease in BALB/c mice.
The Effects of Common Over-the-Counter Moisturizers on Skin Barrier Function: A Randomized, Observer-Blind, Within-Patient, Controlled Study.
Brain allopregnanolone induces marked scratching behaviour in diet-induced atopic dermatitis mouse model.
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis – ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function
Epidemiology and management of atopic dermatitis in England: an observational cohort study protocol.
Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis.
Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials.
Systemic treatments for eczema: a network meta-analysis.
Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis
Prevalence and Pattern of Skin Diseases in Tribal Villages of Gujarat: A Teledermatology Approach.
Anaphylaxis after wheat ingestion in a patient with coeliac disease: two kinds of reactions and the same culprit food.
Dermatological side effects rarely interfere with the continuation of checkpoint inhibitor immunotherapy for cancer.
Clinical Study of Jieketinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis
A phase 2, open-label study of single dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy.
Human mesenchymal stem cell-derived exosomes accelerate wound healing of mice eczema.
Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy.
The Association Between Oral Health and Skin Disease.
Efficacy of oral supplementation of whey protein in patients with contact dermatitis: A pilot randomized double-blind placebo-controlled clinical trial.
Psoralens activate and photosensitize Transient Receptor Potential channels Ankyrin type 1 (TRPA1) and Vanilloid type 1 (TRPV1).
[Treatment of simultaneously occurring urticaria and atopic dermatitis with dupilumab].
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study.
Hyaluronic Acid-Mediated Drug Delivery System Targeting for Inflammatory Skin Diseases: A Mini Review.
A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis
A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)
Mixed occupational and iatrogenic allergic contact dermatitis in a hairdresser.
What’s new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies.
Treatment of Chronic Itch in Atopic Dermatitis (Eczema)
Allogeneic hematopoietic stem cell and liver transplantation in a young girl with dedicator of cytokinesis 8 protein deficiency.
Impaired glucose homeostasis and a novel HLCS pathogenic variant in holocarboxylase synthetase deficiency: a report of two cases and brief review.
Global Differences in Atopic Dermatitis.
Atopic dermatitis.
A marginal estimate for the overall treatment effect on a survival outcome within the joint modeling framework.
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis – ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients.
Paget Disease of the Breast in Pregnancy and Lactation.
New Treatments in Atopic Dermatitis.
Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis
A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable
Ophiopogonin D ameliorates DNCB-induced atopic dermatitis-like lesions in BALB/c mice and TNF-α- inflamed HaCaT cell.
Towards More Shared Decision Making in Dermatology: Develop-ment of Evidence-based Decision Cards for Psoriasis and Atopic Eczema Treatments.
Clinical Features and Outcome of 23 Patients with Wiskott-Aldrich Syndrome (WAS): A Single-Center Experience.
Atopic Dermatitis in US Adults: From Population to Health Care Utilization.
A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
Pros and cons of pre-emptive screening programmes before peanut introduction in infancy.
[THREE CASES OF ATOPIC DERMATITIS CHILDREN WITH INTRACTABLE PRURIGO NODULARIS].
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
Dupilumab in Severe Chronic Hand Eczema
BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation.
Efficacy and Safety of IDP-124 Lotion
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
Nummular Eczema: An Updated Review.
Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial.
The Infectious Complications of Atopic Dermatitis.
A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis
Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrative.
Eczematous Graft-Versus-Host Disease; A Report of Three Cases & Review of the Literature.
Dyshidrotic eczema and Seborrheic Dermatitis-like Eczamatous Eruption Following to Intravenous Immunoglobulin Therapy.
Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis
Hypnosis in Treatment of Atopic Dermatitis: A Clinical Study.
The High Prevalence of Skin Diseases in Adults Aged 70 and Older.
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis
Metal Panel Allergen Patch Test Study
Eczematous dermatitis in primary immunodeficiencies: A review of cutaneous clues to diagnosis.
Real-life efficiency and safety comparison study of emollient ointment based on glycerophosphoinositol (GPI) salt of choline and other emollient products in patients with atopic dermatitis.
Personalised prediction of daily eczema severity scores using a mechanistic machine learning model.
A Phase 3, Multicenter, Open-Label Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis
Abrocitinib: A potential treatment for moderate-to-severe atopic dermatitis.
Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids
How often are bath emollients prescribed to children with atopic eczema in primary care in England? A cross-sectional study.
A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic: Comparing a single surgical site with a COVID-19 intensive care unit.
Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis
Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
Adipose-derived stem cells attenuate atopic dermatitis-like skin lesions in NC/Nga mice.
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
COVID-19 and implications for dermatological and allergological diseases.
Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis
Knowledge mobilisation: an ethnographic study of the influence of practitioner mindlines on atopic eczema self-management in primary care in the UK.
Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Mixed profile of cytokines in paradoxical eczematous eruptions associated with anti-IL-17 therapy.
The role of dermatology in African patients referred for health treatment in an European Center.
Diagnosis and Management of Atopic Dermatitis for Primary Care Providers.
An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1.
Dupilumab as Treatment for Atopic Dermatitis in a Pediatric Heart Transplant Patient: A Case Report.
A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis
Seal, Stopping Atopic Dermatitis and Allergy Study
Safety and efficacy of an herbal formula, Gwakhyangjeonggi-san on atopic dermatitis with gastrointestinal symptoms: Protocol for a randomized controlled trial.
Vehicles for atopic dermatitis therapies: more than just a placebo.
Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis
Tinea incognito: Clinical perspectives of a new imitator.
Vitamin D in Egyptian Children With Atopic Dermatitis
Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis.
Osteoporosis in Skin Diseases.
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.
Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment
A Report of Novel STIM1 Deficiency and 6-Year Follow-Up of Two Previous Cases Associated with Mild Immunological Phenotype.
Measurement properties of three assessments of burden used in atopic dermatitis in adults.
Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis.
Psoriasis With Eczematous Features: A Retrospective Clinicopathologic Study.
High adherence and low dropout rate in a virtual clinical study of atopic dermatitis through weekly reward-based personalized genetic lifestyle reports.
PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo
Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
Development and psychometrics of the English version of the Itch Cognitions Questionnaire.
Dupilumab-induced Serum Sickness Like Reaction: An Unusual Adverse Effect in a patient with atopic eczema.
FACTORS CONTRIBUTING TO CHRONIC URTICARIA/ANGIOEDEMA AND NUMMULAR ECZEMA RESOLUTION – WHICH FINDINGS ARE CRUCIAL?
Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice.
Petroleum jelly baths: A tip for easy emollient application.
Study of OPA-15406 Ointment in Patients With Atopic Dermatitis
Association Between Atopic Eczema and Cancer in England and Denmark.
Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
Effect of Different Skin Creams on TEWL
A Study Assessing the Efficacy and Safety of CBP-201
Overzealous hand hygiene during the COVID 19 pandemic causing an increased incidence of hand eczema among general population.
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial.
Miracles of Herbal Phytomedicines in Treatment of Skin Disorders: Natural Healthcare Perspective.
What’s new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies.
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Eczema herpeticum emerging during atopic dermatitis in infancy.
Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis.
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
Jaktinib Hydrochloride Cream For Atopic Dermatitis
Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis
Hand eczema: epidemiology, prognosis and prevention.
Views and experiences of managing eczema: systematic review and thematic synthesis of qualitative studies.
Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children
A novel sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 antagonist, KRO-105714, for alleviating atopic dermatitis.
European Task Force on Atopic Dermatitis (ETFAD): Treatment targets and treatable traits in atopic dermatitis.
Health care worker sensitivity to chlorhexidine-based hand hygiene solutions: A cross-sectional survey.
Knowledge mobilisation: an exploratory qualitative interview study to confirm and envision modification of lay and practitioner eczema mindlines to improve consultation experiences and self-management in primary care in the UK.
Open-label Study of Dupilumab in Patients With Atopic Dermatitis
Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis.
Identification of a novel WAS mutation in a South African patient presenting with atypical Wiskott-Aldrich syndrome: a case report.
Current approaches to handling rescue medication in asthma and eczema randomised controlled trials are inadequate: a systematic review.
Ethanol-Based Disinfectants Containing Urea May Reduce Soap Sensitivity.
Efficacy and Patient-Reported Outcomes from a Phase IIb, Randomized Clinical Trial of Tapinarof Cream for the Treatment of Adolescents and Adults with Atopic Dermatitis.
A randomized half-body, double blind, controlled trial on the effects of a pH-modified moisturizer vs. standard moisturizer in mild to moderate atopic dermatitis.
Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children
Hypereosinophilic syndrome-a rare adverse event of anti-cytokine treatment in rheumatoid arthritis resolved after Janus kinase inhibitor therapy.
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis – ECZTRA 4
Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis
StatPearls
Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults.
Something to Sweat About: Two Cases of Dupilumab-Induced Hyperhidrosis and Bromhidrosis.
Release of cervical muscular tension improved severe pruritus in moderate-to-severe atopic dermatitis: A case series.
Parental knowledge of moisturizers and their application to infants with eczema in Hangzhou, China.
Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties.
Serum TARC levels before and after treatment for pruritic scabies.
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
Important risk factors for the development of food allergy and potential options for prevention.
Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.
A spray containing extracts of oat plantlets and Uncaria tomentosa relieves pain associated with chronic inflammatory skin diseases and dermatological procedures.
Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy.
Mesenchymal Stem Cells and Atopic Dermatitis: A Review.
[Antihistamines for treating pruritus : The end of an era?]
German S1 guidelines for the diagnosis and treatment of perianal dermatitis (anal eczema).
Contact haptens in emollients marketed in two European countries (Poland and Spain).
Molecular Docking, Simulation and MM-PBSA Studies of Nigella Sativa Compounds: A Computational Quest to identify Potential Natural Antiviral for COVID-19 Treatment.
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
Study to Evaluate ASN008 Topical Gel (TG)
Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Bullous pemphigoid developed on nummular eczema lesions.
Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosis.
[The annual cost of medical care for patients with moderate to severe atopic dermatitis in Mexico. A multicenter study].
A case of drug-induced bullous pemphigoid associated with teriflunomide: A patient with relapsing multiple sclerosis.
Successful treatment of dyshidrotic palmoplantar eczema with ultraviolet A1 light-emitting diodes.
Anti-colitic effects of Physalin B on dextran sodium sulfate-induced BALB/c mice by suppressing multiple inflammatory signaling pathways.
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
Targeted Microbiome Transplant in Atopic Dermatitis
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)

A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood
Atopic Dermatitis-like Eruption Induced by Two Different Biologics in a Patient with Psoriatic Arthritis.
Eczematous, Pruritic, Brownish Plaque of the Nipple and Areola: A Quiz.
Psoriasis-like Dermatitis Developing in a Patient with Atopic Dermatitis Treated with Dupilumab.
Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis.
Conjunctivitis in patients with atopic dermatitis treated with dupilumab.
Pyogenic Flexor Tenosynovitis as a Rare Complication of Dyshidrotic Eczema.
Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune-mediated disorders in pediatric liver transplant recipients.
Association of atopic dermatitis severity with cognitive function in adults.
Efficacy and safety of bilastine in reducing pruritus in patients with chronic spontaneous urticaria and other skin diseases: an exploratory study.
New and emerging therapies for paediatric atopic dermatitis.
Eczema of recipient and donor skin graft sites: Another example of “Ruocco’s immunocompromised district”.
Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses.
Seborrhea herpeticum: cutaneous herpes simplex virus infection within infantile seborrheic dermatitis.
New evidence for construct validity and interpretability of the German Quality of Life in Hand Eczema Questionnaire (QOLHEQ).
To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis
Long-term Safety and Efficacy Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
When life is an itch: What harms, helps and heals from the patients’ perspective? Differences and similarities among skin diseases.
Atopic Dermatitis: Diagnosis and Treatment.
The effect of TJ-28 (Eppikajutsuto) on the prevention of hand-foot syndrome using Capecitabine for colorectal cancer: The Yokohama Clinical Oncology Group Study (YCOG1102).
Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis
A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants
Update of the SFMV (French society of vascular medicine) guidelines on the conditions and safety measures necessary for thermal ablation of the saphenous veins and proposals for unresolved issues.
A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis
Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone
Efficacy and safety of Qinzhuliangxue decoction for treating atopic eczema: a randomized controlled trial.
Successful treatment of recalcitrant dyshidrotic eczema with oxybutynin.
Dupilumab for Atopic Dermatitis: The Silver Bullet We Have Been Searching for?
[PREDICTION OF THE SEVERITY OF ALLERGODERMATHOSIS COMPLICATED BY STAPHYLOCOCCAL INFECTION].
Hand eczema – a growing dermatological concern during the COVID-19 pandemic and possible treatments.
Research Techniques Made Simple: Mouse Models of Atopic Dermatitis.
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis.
Dermatological conditions in older adults: clinical overview.
Omalizumab for treatment of refractory severe atopic dermatitis. A Pediatric perspective.
Rapid effects of dupilumab treatment on papuloerythroderma of Ofuji.
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)
Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis
Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema
Comparing the Potential for Irritation of a Ceramide-Based Moisturizer with a Urea-Based Moisturizer for Pediatric Atopic Dermatitis.
Global Trends in YouTube and Google Search Activity for Psoriasis and Atopic Eczema: Detecting Geographic Hot Spots, Blind Spots and Treatment Strategies.
Favourable effect of creams with skimmed donkey milk encapsulated in nanoliposomes on skin physiology.
Identifying Shared Risk Genes for Asthma, Hay Fever, and Eczema by Multi-Trait and Multiomic Association Analyses.
Validation of the Short-term Antimicrobial Action of Transplanted Bacteria
Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival
Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
The Itch that… freckles? Development of lentigines in areas of resolved chronic atopic dermatitis.
Novel yeast extract is superior to colloidal oatmeal in providing rapid itch relief.
Screening and Intervention for Skin Cancer in the Galapagos.
A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis.
Atopic Dermatitis: Diagnosis and Treatment.
Pediatric dermatology emergencies.
A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis.
Nickel Allergic Contact Dermatitis: Identification, Treatment, and Prevention.
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)
A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis
A Phase I Clinical Study of Hemay808
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)
Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients
Crisaborole for Asian Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Clinical Evaluation of Metal Panel Allergens: Dose Response Study
Contact Sensitization in Patients with Chronic Leg Ulcers: Results of a 5-Year Retrospective Analysis.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Compound Glycyrrhizin Capsules Combined with a Topical Corticosteroid in Adults with Chronic Eczema.
Effectiveness of an antenatal maternal supplementation with prebiotics for preventing atopic dermatitis in high-risk children (the PREGRALL study): protocol for a randomised controlled trial.
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Adult-Onset Atopic Dermatitis: Characteristics and Management.
Predictive Model for Allergic Contact Dermatitis in Patients With Hand Eczema.
Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature.
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients
Clinical, biochemical and mutational findings in biotinidase deficiency among Malaysian population.
Could Inflammaging and Its Sequelae Be Prevented or Mitigated?
The risk factors of lower limb cellulitis: A case-control study in a tertiary centre.
Management of Atopic Eczema in primary care.
Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study.
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
The Burden of Childhood Atopic Dermatitis in the Primary Care Setting: A Report from the Meta-LARC Consortium.
Eczema, Targeted Therapeutics, and Allergy Diagnostics: The Need for Greater Clarity on What We Are Treating.
The Efficacy of Colloidal Oatmeal Cream 1% as Add-on Therapy in the Management of Chronic Irritant Hand Eczema: A Double-Blind Study.
Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial.
Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD
Atopic dermatitis in the US military.
Japanese guidelines for atopic dermatitis 2020.
Severe atopic dermatitis: Dupilumab is not just safer, but more efficient.
Isatis tinctoria L.-derived Petroleum Ether Extract Mediates Anti-inflammatory Effects via Inhibition of Interleukin-6, Interleukin-33 and Mast Cell Degranulation.
A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Interleukin-33 in atopic dermatitis.
The financial impact of atopic eczema paid out-of-pocket by affected patients in France.
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review.
How is safety of dermatology drugs assessed: trials, registries, and spontaneous reporting.
Evaluation of the Efficacy and Safety of Lebrikizumab in Moderate to Severe Atopic Dermatitis
Evaluation of the Efficacy and Safety of Lebrikizumab in Moderate to Severe Atopic Dermatitis

Nutrition and allergic diseases in urban and rural communities from the South African Food Allergy cohort.
Eczema herpeticum: A medical emergency in patients with atopic dermatitis.
Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis
Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone
Establishing and developing a Teenage and Young Adult dermatology clinic with embedded specialist psychological support.
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitis.
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
Topical NanoDox® for Atopic Dermatitis
Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts.
The PEBBLES Study – Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants
Moisturizer to Prevent Atopic Dermatitis
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis
Guidelines for the Diagnosis, Treatment, and Prevention of Hand Eczema.
Dermatoscopy in life-threatening and severe acute rashes.
Eczema coxsackium complicating allergic contact dermatitis during treatment with pimecrolimus 1% cream in an adult.
An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab: A Single-Center Real-Life Experience.
Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis
A Study to Test Safety and Tolerability of a Study Drug Called MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Patients With Moderate to Severe Atopic Dermatitis
Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis
Vulvar pruritus-Causes, Diagnosis and Therapeutic Approach.
Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis
Direct infant UV light exposure is associated with eczema and immune development.
Methotrexate in atopic eczema – Reply to a letter.
TCM treatment of allergy induced by stainless steel implants for tibiofibular fracture: A case report.
Glutamine Supplementation in People With Immune Dysregulation
Delgocitinib: First Approval.
Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis
Apremilast 30 mg BID Combined With Dupilumab
The current extent of and need for shared decision making in atopic dermatitis and psoriasis in the Netherlands: An online survey study amongst patients and physicians.
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
Penile eczema: Not all genital ulcers are sexually transmitted infections.
A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis
Allergic contact dermatitis caused by 10-hydroxydecenoic acid contained in an emollient cream.
The use of complementary and alternative medicine in children with atopic eczema at a tertiary care centre in Malaysia.
Effects of Treatments on Atopic Dermatitis
Expression of retinoid receptors in hand eczema.
Utility of boron in dermatology.
Taste disturbances – are there any effective treatments?
Photodermatitis to topical phenothiazines: a case series.
Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials – ECZTEND
Analysis of cases managed by dermatological service in the Chinese peacekeeping level 1+ medical treatment facility in Lebanon, 2018-2019.
Autosomal recessive hyper-IgE syndrome successfully treated with hematopoietic stem cell transplantation.
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis – ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome
Systematic review about 10 interventions in dermatitis. A document from the Latin American Society of Allergy, Asthma, and Immunology.
[Late-onset atopic dermatitis with nummular pattern].
Association between antibiotic treatment during pregnancy and infancy and the development of allergic diseases.
Supporting a Healthy Microbiome for the Primary Prevention of Eczema.
Eczema phenotypes and risk of allergic and respiratory conditions in school age children.
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.
Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis
Atopic Dermatitis Is a Barrier Issue, Not an Allergy Issue.
Tips and Tricks for Controlling Eczema.
Medicinal potential of Panax ginseng and its ginsenosides in atopic dermatitis treatment.
Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis
A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients
Skin bioMARkers for Atopic Eczema Therapy Evaluation
Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis
Insights From Caregivers on the Impact of Pediatric Atopic Dermatitis on Families: “I’m Tired, Overwhelmed, and Feel Like I’m Failing as a Mother”.
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo
Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab.
Artesunate attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis by down-regulating Th17 cell responses in BALB/c mice.
Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood
Eucrisa for Atopic Dermatitis
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
Prevalence and determinants for xerosis cutis in the middle-aged and elderly population: A cross-sectional study.
Implementation of dupilumab in routine care of atopic eczema. Results from the German national registry TREATgermany.
The European TREatment of ATopic eczema Taskforce (TREAT) Survey; prescribing practices in Europe for phototherapy and systemic therapy in moderate-to-severe adult atopic eczema patients.
Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: A systematic review.
A critical appraisal and implications of the new National Institute for Health and Care Excellence guideline on dupilumab for treating moderate-to-severe atopic eczema.
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
The Role of the Cutaneous Microbiome in Hidradenitis Suppurativa-Light at the End of the Microbiological Tunnel.
An overview of drug discovery efforts for eczema: why is this itch so difficult to scratch?
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
A Study to Evaluate Risankizumab in Adult and Adolescent Subjects With Moderate to Severe Atopic Dermatitis
A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis
Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A
Use of alitretinoin in moderate to severe chronic hand eczema: A real-world experience in Korea.
Facts and speculations on vitamin d in prevention and treatment of atopic dermatitis
Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema
TRuE AD2 – An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Fish Consumption at One Year of Age Reduces the Risk of Eczema, Asthma and Wheeze at Six Years of Age.